CST 首席科学官 Roberto Polakiewicz 因在抗体开发中对科学严谨性的贡献而获得 CiteAb 卓越个人影响力奖

美国马萨诸塞州丹佛斯 2024 年 3 月 26 日 – 生命科学发现技术公司暨领先的抗体、试剂盒与服务提供商 Cell Signaling Technology (CST) 今天宣布荣获三个类别的 2024 CiteAb 奖，该奖项突出展示全球研究试剂领域的最佳供应商和个人。

CST 荣获如下奖项类别：

• Award for Significant Individual Impact: Roberto (Roby) Polakiewicz, PhD, Chief Scientific Officer at CST, was recognized for his commitment to high-quality antibody manufacturing, including the development of novel antibody methods and steadfast advocacy for scientific reproducibility standards for antibody manufacturers.
• Antibody Supplier Succeeding in South Korea: Based on an analysis of CiteAb’s antibody reagent citation database, CST was the company with the most citations for antibodies in South Korea over the past year.
• Innovation Award: The SignalStar™ Multiplex Immunohistochemistry (mIHC) assay was Highly Commended in CiteAb’s Innovation Award category. The solution is a flexible, out-of-the-box tool for spatial biology research that uses mid-plex, high-throughput IHC assays for up to 8-plex amplification in two days.

“[Roby] has ensured scientific rigor and reproducibility are at the heart of Cell Signaling Technology's antibody generation and validation processes, something which led to the company's reputation for producing high-quality antibodies,” said Andrew Chalmers, CiteAb CEO. “I think thousands of researchers will unknowingly owe him a debt of gratitude for their successful experiments and I'm sure many will join me in congratulating Roby!”

“Without experimental reproducibility, scientific integrity is lost, and researchers cannot be confident in their findings,” says Roby Polakiewicz. “A highlight of my career since the founding of CST nearly 25 years ago has been establishing and scaling our culture of scientific rigor, which has led to our stringent antibody validation processes. As a result, I have found myself advocating for reproducibility standards for the antibody industry as a whole. It is an honor to be recognized by CiteAb for the role our work has played in moving the industry forward and enabling more responsible, reproducible science.”

As a global supplier of high-quality antibodies that are used by research teams worldwide, CST is proud to be recognized as the antibody supplier with the most citations in South Korea, a growing epicenter for scientific discovery.

"We have recently noticed that South Korea has been seeing an uptick in the number of citations it's outputting,” said Rhys Williams, Head of Antibody Data at CiteAb. “We want to extend our congratulations to Cell Signaling Technology for their win in this category, which showcases their support of researchers in this growing research hotspot by providing antibodies that are being used frequently in published work.”

The SignalStar mIHC assay was also recognized as highly commended in CiteAb’s Innovation Award category. The solution is a transformative new technology for spatial biology research that uses a proprietary technology to amplify antibody signals, allowing for the detection of targets with low expression levels. A key innovation is the technology’s flexibility in antibody panel design—the SignalStar antibodies and fluorophores are interchangeable, so as research evolves and new targets are identified, researchers can switch out targets and quickly redesign panels without the need for additional panel or protocol optimization. This unparalleled flexibility delivers results up to 70% faster than some other mIHC methods.

CST has a long history of strong performance in awards and recognition by CiteAb, including being named the Post Translational Modification (PTM) Antibody Supplier of the Year in 2023 and the Antibody Supplier of the Decade in 2020. Recently, CST received the 2023 Innovation Award for anti-CAR linker antibodies and was recognized as the Supplier Succeeding in Cancer Research.

访问以下网站，更多了解 CiteAb 和 2024 年度奖项：https://www.citeab.com/awards

关于 CiteAb

CiteAb 提供加速科学研究的一流数据。The company’s industry-leading data collection technology combines machine learning and extensive human reviewing to identify and understand reagent use from scientific publications. This highly accurate data is used to power all of their products, which help researchers find and suppliers sell the best reagents. CiteAb’s search engine ranks products by citations, fundamentally changing the way researchers find products for their experiments, and the company’s data-based products are used to inform suppliers globally. 去年，从搜索超过 680 万种试剂中，向 CiteAb 用户提供超过 400 万页信息。CiteAb is a committed group of biologists and computer scientists dedicated to helping the world's best scientists and suppliers tackle the big problems in life science research. 欲知更多信息，请访问 www.citeab.com。

关于 Cell Signaling Technology

Cell Signaling Technology (CST) 是一家与众不同的生命科学公司，由活跃在科研一线的科学家创立、拥有并经营，始终秉承最高标准的产品与服务质量、技术创新和科学严谨性。CST 成立于 1999 年，总部位于美国马萨诸塞州丹弗斯，在全球拥有超过 600 名员工。我们始终如一地为全球的科学家提供高品质产品与服务，助力他们对科学发现的探求。CST 坚持以人为本，以科学为本——是一家坚持服务客户，帮助社区，关爱地球的公司。如需了解更多信息，请访问 CST 中国官网：https://www.cellsignal.cn。

CST 媒体和新闻

Rebecca J. Reppucci, MBA
Cell Signaling Technology, Inc.
Senior Director, Global MarComm & Technology
Phone: 978-880-3334
email: [电子邮件受保护]